NASMAC: A visionary journey in Saudi Arabia’s pharmaceutical landscape. Born from a collaboration between Zahran Holding Group (through NASAQ) and Macleods Pharmaceutical Ltd.
Who Are We?
The name NASMAC is a symbol of unity and progress. The “NAS” comes from NASAQ, a name synonymous with reliability and national growth in the Kingdom. The “MAC” is from Macleods one of India’s most respected pharmaceutical leaders.
Why We Exist?
NASMAC was founded to make a real difference in people’s lives. Our existence is driven by the urgent need for affordable and high-quality healthcare solutions across the Kingdom, especially for chronic diseases that affect a large portion of population.
Through the strategic vision of NASAQ and the global reach of Macleods, NASMAC aims to address gaps in the healthcare market by combining local expertise and global pharmaceutical capabilities. We are here to deliver effective treatments, strengthen Saudi Arabia’s healthcare independence, and support the nation’s long-term wellbeing goals.
At NASMAC we bring together the technical expertise, experience, and financial strength of two leading entities. Through our collaboration with Macleods Pharmaceuticals, we have access to world-class drug development and manufacturing capabilities, allowing us to offer a diverse range of high-quality medicines. Our focus lies in treating non-communicable chronic diseases, we aim to address the most pressing health issues in Saudi Arabia. Our unique combination of local knowledge and international resources allows us to offer innovative, affordable, and accessible healthcare solutions that make real impact This approach lays the foundation for a sustainable, Saudi-led pharmaceutical industry aligned with the Kingdom’s Vision 2030.
